Politics ❯ Health Policy

Drug Regulation

Public Health Initiatives Public Health FDA Public Safety Government Oversight Pharmaceutical Oversight Healthcare Oversight Government Action Pricing Policies Pharmaceutical Pricing Healthcare Fraud Weight Loss Drugs Lifestyle Choices Obesity Management Performance-Enhancing Drugs Healthcare Ethics FDA Oversight Cannabis Legislation Affordable Medications Pharmacy Oversight Lachgas Federal Drug Commissioner Public Health Law Healthcare System Pharmaceutical Accountability Government Agencies FDA Actions Federal Agencies Substance Control Pharmaceutical Companies Law Enforcement NHS Guidelines Pharmaceutical Benefits Advisory Committee Transparency in Pricing Marijuana Rescheduling Addiction Treatment Policy State Actions Legislative Reform FDA Leadership Anti-Counterfeiting Measures Government Intervention Medicinal Safety Prescription Guidelines Safety Standards Trans Rights Medical Oversight Psychedelics International Cooperation FDA Decisions Enforcement Actions

White House Orders Fast-Track for Psychedelic Therapies and Limited Cannabis Rescheduling

The directives concentrate federal resources on medical treatment rather than broad legalization.

San Mateo County Becomes First Bay Area County to Ban Kratom Sales

GLP-1 Weight-Loss Push Intensifies as Novo Leads Ads and Wegovy Pill Drives Telehealth Uptake

FDA Delays Two Drugs in National Priority Voucher Program After Safety, Efficacy Flags

U.S. Regulators Move to Classify Potent Kratom Derivative as Schedule I Opioid